
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Mexico hemostats market was valued at USD 160.27 Million in 2024 driven by the rapid technological advancements, with innovations in hemostatic agents such as fibrin sealants and advanced topical hemostats across the region. It is expected to grow at a CAGR of 5.50% during the forecast period of 2025-2034 and attain a market value of USD 273.76 Million by 2034.
The market is growing steadily, shaped by advances in surgical technology and the country’s shifting health profile. Hospitals are adopting newer hemostatic products, particularly fibrin sealants and advanced topical agents, which offer faster application and better outcomes in complex surgeries. This shift is driven by both public and private healthcare providers looking to improve surgical efficiency and patient recovery. Chronic diseases are a major factor. Cardiovascular disease, diabetes, and obesity are all on the rise in Mexico, contributing to a higher volume of surgical interventions, from bypass surgeries and angioplasties to amputations and wound care. These procedures often involve significant blood loss, making effective hemostasis critical.
Base Year
Historical Period
Forecast Period
Increasing technological advancements in hemostatic agents and a surge in chronic disease prevalence are driving greater adoption of innovative hemostats across Mexico.
The market growth is driven by a rising number of cesarean deliveries and major organ surgeries, combined with improved healthcare infrastructure, creating strong growth opportunities for the market.
The rapid expansion of hospitals and ambulatory surgical centers is increasing the nation’s surgical capacity, directly fueling market demand for hemostatic products.
Compound Annual Growth Rate
5.5%
Value in USD Million
2025-2034
Mexico Hemostats Market Outlook
*this image is indicative*
Hemostats are widely used in Mexico to control bleeding during surgeries, trauma cases, and wound management, ensuring patient safety and reducing complications. They are essential in procedures like orthopedic, gynecological, cardiovascular, and general surgeries, especially given Mexico’s rising rates of chronic diseases, cesarean deliveries, and trauma incidents, which drive the need for effective hemostatic solutions in hospitals and surgical centers. The Mexico hemostats market is expected to grow at a CAGR of 5.50% during the forecast period of 2025-2034.
Adoption of Innovative Hemostats to Boost Market Value
Rising gastrointestinal disorder prevalence and increasing demand for minimally invasive procedures are key drivers for the market. For instance, in February 2021, EndoClot Plus, Inc. announced FDA approval for its EndoClot® Polysaccharide Hemostatic System (PHS), a starch-based powder that quickly forms a gelled matrix to control GI bleeding via endoscopy. As this product gains global adoption, including in emerging markets like Mexico, it is likely to bolster advanced hemostatic solution adoption, driving significant market growth in the forecast period.
The market is expanding due to rising cancer cases and increasing trauma-related surgical needs.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Formulation
Market Breakup by Application
Market Breakup by Indication
Market Breakup by End User
Matrix and Gel Based Hemostats to Lead the Market Share by Formulation
Matrix and gel hemostats are likely to hold the largest share of the market. Their dominance is attributed to their superior efficacy in controlling bleeding during complex surgeries, versatility across various surgical specialties, and rapid adoption by surgeons seeking advanced solutions. As per the analysis by Expert Market Research, the global hemostats market size is expected to grow at a CAGR of 6.40% during the forecast period of 2025-2034. Additionally, matrix and gel formulations are preferred for their ease of use and ability to conform to irregular wound surfaces, supporting better surgical outcomes.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in New Brunswick, New Jersey, Johnson and Johnson Services Inc. was established in 1886. The company is a global healthcare leader, offering a diverse range of medical devices, pharmaceuticals, and consumer health products. In Mexico’s hemostats market, its Ethicon division delivers advanced hemostatic solutions like SURGICEL, widely used in surgeries for effective bleeding control.
Baxter International, founded in 1931 and headquartered in Deerfield, Illinois, is a leading global MedTech company. In the Mexico hemostats market, Baxter provides a robust portfolio of hemostatic agents and sealants, including innovative products like Floseal and the recently launched Hemopatch Sealing Hemostat, which offers rapid, effective hemostasis for both open and minimally invasive surgeries.
Pfizer Inc., established in 1849 and based in New York City, is a renowned pharmaceutical and biotechnology company. In Mexico, Pfizer contributes to the hemostats market through its specialized biopharmaceuticals and partnerships, offering advanced solutions that support surgical teams in managing bleeding and improving patient outcomes during complex procedures.
B. Braun SE, founded in 1839 and headquartered in Melsungen, Germany, is a global leader in healthcare products and services. In Mexico’s hemostats market, B. Braun offers a comprehensive range of surgical hemostatic agents and wound care solutions, supporting hospitals and surgical centers with reliable, innovative products for effective intraoperative bleeding management.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Becton, Dickinson and Company (BD), Medtronic plc, and Stryker Corporation, among others.
What was the Mexico hemostats market value in 2024?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2024 |
Historical Period | 2018-2024 |
Forecast Period | 2025-2034 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Formulation |
|
Breakup by Application |
|
Breakup by Indication |
|
Breakup by End User |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.